Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Zuckerman

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Leukemia Research|August 26, 1998
Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed eventX Hu, L C Moscinski, B J Hill, et al.
Journal of Clinical Immunology|November 1, 1986
Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populationsV Pistoia, A J Carroll, E F Prasthofer, et al.
Blood|December 1, 1977
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvementA T Skarin, K S Zuckerman, S W Pitman, et al.
Cancer Research|August 17, 2001
An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanismX Hu, W E Janssen, L C Moscinski, et al.
The Journal of Clinical Investigation|March 1, 1985
Inhibition of collagen deposition in the extracellular matrix prevents the establishment of a stroma supportive of hematopoiesis in long-term murine bone marrow culturesK S Zuckerman, R K Rhodes, D D Goodrum, et al.
Blood|April 1, 1992
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftmentJ E Wagner, H E Broxmeyer, R L Byrd, et al.
The New England Journal of Medicine|December 22, 1994
A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemiaR P Castleberry, P D Emanuel, K S Zuckerman, et al.
Blood|January 1, 1995
Clonality in juvenile chronic myelogenous leukemiaL Busque, D G Gilliland, J T Prchal, et al.
Blood|November 15, 1989
Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemiaR J Gualtieri, P D Emanuel, K S Zuckerman, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Leukemia Research|August 26, 1998
Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed eventX Hu, L C Moscinski, B J Hill, et al.
Journal of Clinical Immunology|November 1, 1986
Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populationsV Pistoia, A J Carroll, E F Prasthofer, et al.
Blood|December 1, 1977
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvementA T Skarin, K S Zuckerman, S W Pitman, et al.
Cancer Research|August 17, 2001
An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanismX Hu, W E Janssen, L C Moscinski, et al.
The Journal of Clinical Investigation|March 1, 1985
Inhibition of collagen deposition in the extracellular matrix prevents the establishment of a stroma supportive of hematopoiesis in long-term murine bone marrow culturesK S Zuckerman, R K Rhodes, D D Goodrum, et al.
Blood|April 1, 1992
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftmentJ E Wagner, H E Broxmeyer, R L Byrd, et al.
The New England Journal of Medicine|December 22, 1994
A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemiaR P Castleberry, P D Emanuel, K S Zuckerman, et al.
Blood|January 1, 1995
Clonality in juvenile chronic myelogenous leukemiaL Busque, D G Gilliland, J T Prchal, et al.
Blood|November 15, 1989
Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemiaR J Gualtieri, P D Emanuel, K S Zuckerman, et al.
Pageof 6